Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): racing against resistance
- PMID: 17265116
- DOI: 10.1245/s10434-006-9291-6
Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): racing against resistance
Comment on
-
Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.Ann Surg Oncol. 2007 Feb;14(2):526-32. doi: 10.1245/s10434-006-9228-0. Epub 2006 Dec 2. Ann Surg Oncol. 2007. PMID: 17139461 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
